Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Net Shares Issued and Repurchased (2018 - 2025)

Alector's (ALEC) quarterly Net Shares Issued and Repurchased came in at $3.2 million in Q4 2025, up 126.92% year-over-year from $1.4 million in Q4 2024, and up 126.92% quarter-over-quarter from $1.4 million in Q4 2024.

Analysis

Alector (ALEC) Net Shares Issued and Repurchased (2018 - 2025) Analysis & Trends

Alector (ALEC) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $3.2 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Net Shares Issued and Repurchased rose 126.92% year-over-year to $3.2 million in Q4 2025; TTM through Dec 2025 was $3.2 million, a 126.92% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 126.92% from the prior year.
  • Net Shares Issued and Repurchased was $3.2 million for Q4 2025 at Alector, up from $1.4 million in the prior quarter.
  • Over five years, Net Shares Issued and Repurchased peaked at $5.0 million in Q4 2022 and troughed at $521748.0 in Q1 2021.
  • A 5-year average of $2.3 million and a median of $1.8 million in 2022 frame the typical range for Net Shares Issued and Repurchased.
  • Across the five-year window, Net Shares Issued and Repurchased soared 202.02% in 2022 and tumbled 58.82% in 2023, its largest moves.
  • Over 5 years, Net Shares Issued and Repurchased stood at $3.3 million in 2021, then jumped by 53.07% to $5.0 million in 2022, then plunged by 58.82% to $2.1 million in 2023, then slumped by 31.4% to $1.4 million in 2024, then soared by 126.92% to $3.2 million in 2025.
  • The last three Net Shares Issued and Repurchased figures came in at $3.2 million (Q4 2025), $1.4 million (Q4 2024), and $2.1 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Alector 274.68 Mn 101.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.20 Mn
Dec 31, 2024 1.41 Mn
Dec 31, 2023 2.06 Mn
Mar 31, 2023 985,811.00
Dec 31, 2022 5.00 Mn
Mar 31, 2022 1.58 Mn
Dec 31, 2021 3.26 Mn
Mar 31, 2021 521,748.00
Dec 31, 2020 5.60 Mn
Mar 31, 2020 1.04 Mn
Dec 31, 2019 3.74 Mn
Mar 31, 2019 422,600.00
Dec 31, 2018 5.06 Mn